Elder Pharmaceuticals to unveil five products in Europe this fiscal

07 Jun 2011 Evaluate

In a bid to increase overseas revenue, Elder Pharmaceuticals, leading company in the pharmaceutical formulation is planning to launch five products, including its top domestic brands such as calcium-loaded ‘Shelcal’, in Europe this fiscal in a bid to increase overseas revenue. The company will introduce these products in Europe through its subsidiaries in the UK and Bulgaria. Among the five products to be introduced in Europe is the company’s calcium supplement for women, ‘Shelcal’, one of its largest selling pharmaceutical products in India, with annual revenues of around Rs 200 crore.

The company is aiming revenue of Rs 1,000 crore for the current financial year and Rs 1,200 crore for FY13. At present, revenue from foreign markets contributes around 10% to the total revenue of the company and the management aims to take it to 20% by the end of the current fiscal.

Recently the company had announced to launch almost three dozen new products in the coming 30 months. The company earmarked an investment of about Rs 120-130 crore for this product launches.

Elder Pharmaceutical is engaged in the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. It holds market leader position in three therapeutic segments - Women’s Healthcare, Wound Care and Nutraceuticals.

Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×